Fred Alger Management’s RxSight RXST Stock Holding History

Fred Alger Management’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-30,491	Closed	-$878K	–	528
2023 Q2	$878K	Buy	+30,491	New	+$678K	﹤0.01%	382

Other funds holding RXST

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Fred Alger Management's RXST Position: Q3 2023 in Review

Fred Alger Management sold out of RxSight (RXST) in Q3 2023, closing a stake of 30,491 shares — an estimated $878K sold.

Fred Alger Management first reported a position in RXST in Q2 2023 and held it in 1 quarter. The position peaked at $878K in Q2 2023. 128 funds tracked by Wall St. Rank hold RXST as of Q3 2023.

Fred Alger Management reported no remaining RxSight position as of Q3 2023 after selling out during the quarter.
Fred Alger Management sold 30,491 RxSight shares in Q3 2023, an estimated $878K.
Fred Alger Management first reported a position in RxSight in Q2 2023 and held it in 1 quarter.
Fred Alger Management's RxSight position peaked at $878K in Q2 2023.
128 funds tracked by Wall St. Rank held RxSight as of Q3 2023.

Based on Fred Alger Management's 13F filing for Q3 2023, filed 14 Nov 2023.